Natixis Boosts Holdings in Teleflex Incorporated (NYSE:TFX)

Natixis boosted its stake in Teleflex Incorporated (NYSE:TFX) by 1,990.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 65,651 shares of the medical technology company’s stock after acquiring an additional 62,511 shares during the period. Natixis’ holdings in Teleflex were worth $11,685,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its stake in Teleflex by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company’s stock valued at $202,161,000 after purchasing an additional 8,307 shares during the last quarter. Cooke & Bieler LP lifted its position in shares of Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after buying an additional 195,150 shares during the last quarter. Invesco Ltd. grew its stake in shares of Teleflex by 48.1% during the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company’s stock worth $190,188,000 after acquiring an additional 347,003 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Teleflex by 38.1% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company’s stock worth $105,102,000 after acquiring an additional 162,950 shares during the period. Finally, Norges Bank purchased a new stake in Teleflex in the 4th quarter worth about $100,328,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Stock Performance

NYSE TFX opened at $129.57 on Friday. The company has a market capitalization of $6.01 billion, a P/E ratio of 25.76, a P/E/G ratio of 1.73 and a beta of 1.19. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 52-week low of $124.66 and a 52-week high of $249.91. The company has a fifty day moving average of $143.68 and a 200-day moving average of $177.50.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. As a group, equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.05%. Teleflex’s payout ratio is 95.77%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. Morgan Stanley lowered their target price on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday, March 5th. Truist Financial cut their price target on Teleflex from $149.00 to $140.00 and set a “hold” rating for the company in a report on Friday, April 11th. Finally, Raymond James downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $169.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.